Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation

• Published in: Current cardiovascular imaging reports Vol. 12; no. 12; pp. 1 - 12
• Main Authors: Gumprecht, Jakub, Szulik, Mariola, Domek, Magdalena, Mazurek, Michał, Shantsila, Alena, Oxborough, David, Lip, Gregory Y. H.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2019; Springer Nature B.V
• Subjects: Arrhythmia; Biomarkers; Cardiac arrhythmia; Cardiology; Diagnostic Radiology; Echocardiography; Echocardiography (G Dwivedi; Fibrillation; Imaging; Interventional Radiology; Management; Medicine; Medicine & Public Health; Nuclear Medicine; Parameters; Radiology; Section Editor; Ultrasound; Biomarkers; Atrial volume index; Echocardiography; Atrial strain; Atrial fibrillation; Tissue Doppler
• ISSN: 1941-9066; 1941-9074
• DOI: 10.1007/s12410-019-9520-6

Purpose of Review Atrial fibrillation (AF) is the most common arrhythmia in adults. The number of patients with AF is anticipated to increase annually, mainly due to the aging population alongside improved arrhythmia detection. AF is associated with a significantly elevated risk of hospitalization, stroke, thromboembolism, heart failure, and all-cause mortality. Echocardiography is one of the key components of routine assessment and management of AF. Therefore, the aim of this review is to briefly summarize current knowledge on “novel” echocardiographic parameters that may be of value in the management of AF patients. Recent Findings Novel echocardiographic biomarkers and their clinical application related to the management of AF have been taken into consideration. Both standard parameters such as atrial size and volume but also novels like atrial strain and tissue Doppler techniques have been analyzed. Summary A number of novel echocardiographic parameters have been proven to enable early detection of left atrial dysfunction along with increased diagnosis accuracy. This concerns particularly experienced echocardiographers. Hence, these techniques might improve the prediction of stroke and thromboembolic events among AF patients and need to be further developed and disseminated. Nonetheless, even the standard imaging parameters could be of significant value and should not be discontinued in everyday clinical practice.